Published in Obstet Gynecol on February 01, 2007
Hormonal contraception--what kind, when, and for whom? Dtsch Arztebl Int (2011) 2.47
A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data. Pharmacoepidemiol Drug Saf (2012) 2.11
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10. BMJ (2012) 1.75
Health care providers' knowledge about contraceptive evidence: a barrier to quality family planning care? Contraception (2009) 1.46
Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis. Contraception (2008) 1.40
As the world grows: contraception in the 21st century. J Clin Invest (2008) 1.37
Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188. J Acquir Immune Defic Syndr (2010) 1.02
Attitudes toward the vaginal ring and transdermal patch among adolescents and young women. J Adolesc Health (2009) 1.01
Satisfaction and compliance in hormonal contraception: the result of a multicentre clinical study on women's experience with the ethinylestradiol/norelgestromin contraceptive patch in Italy. BMC Womens Health (2009) 1.01
Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics (2011) 0.94
High levels of women's satisfaction and compliance with transdermal contraception: results from a European multinational, 6-month study. Gynecol Endocrinol (2010) 0.87
Acute myocardial infarction as the first presentation of thyrotoxicosis in a 31-year old woman - case report. Thyroid Res (2010) 0.86
Contraception for cancer survivors. J Gen Intern Med (2009) 0.85
Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review. Patient Prefer Adherence (2008) 0.81
Eligibility criteria in venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet Gynecol (2009) 0.78
Type of hormone replacement therapy and risk of venous thromboembolism. BMJ (2008) 0.77
Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled study. Reprod Sci (2014) 0.76
Contraception and the obese woman. J Am Assoc Nurse Pract (2013) 0.75
Contraception in women with medical problems. Obstet Med (2008) 0.75
Transdermal delivery of combined hormonal contraception: a review of the current literature. Int J Womens Health (2017) 0.75
Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol (2005) 6.20
Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. N Engl J Med (2002) 4.07
Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies. Ann Intern Med (2014) 3.62
Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet (2012) 3.48
British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford) (2007) 3.39
Variations in pill appearance of antiepileptic drugs and the risk of nonadherence. JAMA Intern Med (2013) 3.13
Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation (2003) 2.73
Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med (2008) 2.59
Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum (2009) 2.47
Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ (2004) 2.39
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis (2013) 2.33
Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol (2005) 2.31
An application of propensity score matching using claims data. Pharmacoepidemiol Drug Saf (2005) 2.15
Paroxetine in the first trimester and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf (2007) 2.04
The risk of nonvertebral fracture related to inhaled corticosteroid exposure among adults with chronic respiratory disease. Chest (2005) 2.04
A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum (2010) 2.02
Epidemiology of gout. Arthritis Res Ther (2010) 1.99
Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization. CMAJ (2002) 1.99
Sex and ethnic differences in the association of ASPN, CALM1, COL2A1, COMP, and FRZB with genetic susceptibility to osteoarthritis of the knee. Arthritis Rheum (2007) 1.95
A meta-analysis of European and Asian cohorts reveals a global role of a functional SNP in the 5' UTR of GDF5 with osteoarthritis susceptibility. Hum Mol Genet (2008) 1.91
Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives. Obstet Gynecol (2007) 1.87
Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med (2004) 1.86
Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis (2007) 1.86
Age and sex differences in hip joint space among asymptomatic subjects without structural change: implications for epidemiologic studies. Arthritis Rheum (2003) 1.81
A delphi exercise to identify characteristic features of gout - opinions from patients and physicians, the first stage in developing new classification criteria. J Rheumatol (2013) 1.77
Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22. Ann Rheum Dis (2010) 1.75
The GDF5 rs143383 polymorphism is associated with osteoarthritis of the knee with genome-wide statistical significance. Ann Rheum Dis (2010) 1.70
The changing epidemiology of gout. Nat Clin Pract Rheumatol (2007) 1.66
Mutations in ANKH cause chondrocalcinosis. Am J Hum Genet (2002) 1.63
Evaluation of the genetic overlap between osteoarthritis with body mass index and height using genome-wide association scan data. Ann Rheum Dis (2012) 1.62
A variant in MCF2L is associated with osteoarthritis. Am J Hum Genet (2011) 1.60
Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study. BMJ (2013) 1.58
Patient and provider barriers to effective management of gout in general practice: a qualitative study. Ann Rheum Dis (2012) 1.50
Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers. Clin Pharmacol Ther (2003) 1.49
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination. Pharmacoepidemiol Drug Saf (2012) 1.46
Prevalence and associations of hallux valgus in a primary care population. Arthritis Rheum (2008) 1.46
Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis. Am J Hum Genet (2008) 1.45
Reproducible genetic associations between candidate genes and clinical knee osteoarthritis in men and women. Arthritis Rheum (2006) 1.44
Use of propensity score technique to account for exposure-related covariates: an example and lesson. Med Care (2007) 1.44
Drug copayment and adherence in chronic heart failure: effect on cost and outcomes. Pharmacotherapy (2006) 1.41
Lack of support for the presence of an osteoarthritis susceptibility locus on chromosome 6p. Arthritis Rheum (2005) 1.40
Effect of aprotinin on renal dysfunction. Lancet (2008) 1.39
The impact of wording in "Dear doctor" letters and in black box labels. Clin Pharmacol Ther (2002) 1.38
Analgesic use and change in kidney function in apparently healthy men. Am J Kidney Dis (2003) 1.37
Involvement of different risk factors in clinically severe large joint osteoarthritis according to the presence of hand interphalangeal nodes. Arthritis Rheum (2010) 1.33
Serious cardiovascular events and mortality among patients with schizophrenia. J Nerv Ment Dis (2004) 1.32
A propensity score-matched cohort study of the effect of statins, mainly fluvastatin, on the occurrence of acute myocardial infarction. Am J Cardiol (2003) 1.29
Genetic variation in the SMAD3 gene is associated with hip and knee osteoarthritis. Arthritis Rheum (2010) 1.29
Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis. Proc Natl Acad Sci U S A (2012) 1.28
Occurrence of colon ischemia in relation to irritable bowel syndrome. Am J Gastroenterol (2004) 1.25
Coronary heart disease outcomes in patients receiving antidiabetic agents. Pharmacoepidemiol Drug Saf (2007) 1.25
Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology (2014) 1.24
An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease. Rheumatology (Oxford) (2009) 1.24
Bupropion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf (2007) 1.23
Are joints affected by gout also affected by osteoarthritis? Ann Rheum Dis (2007) 1.23
The urban spread of visceral leishmaniasis: clues from spatial analysis. Epidemiology (2002) 1.20
The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy. Pharmacoepidemiol Drug Saf (2006) 1.20
An assessment of the discriminative ability of the EQ-5Dindex, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditions. Eur J Health Econ (2007) 1.18
Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States. Pharmacoepidemiol Drug Saf (2002) 1.16
Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter? Med Care (2009) 1.15
Pathophysiology of articular chondrocalcinosis--role of ANKH. Nat Rev Rheumatol (2010) 1.14
A comparison of the performance of the EQ-5D and SF-6D for individuals aged >or= 45 years. Health Econ (2008) 1.13
Inverse relationship between preoperative radiographic severity and postoperative pain in patients with osteoarthritis who have undergone total joint arthroplasty. Semin Arthritis Rheum (2011) 1.12
Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population. Pharmacoepidemiol Drug Saf (2006) 1.09
Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores? Health Qual Life Outcomes (2008) 1.09
A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study. Pharmacoepidemiol Drug Saf (2008) 1.09
Nottingham knee osteoarthritis risk prediction models. Ann Rheum Dis (2011) 1.08
Hypersomnia following traumatic brain injury. J Clin Sleep Med (2007) 1.08
Quasi-experimental longitudinal designs to evaluate drug benefit policy changes with low policy compliance. J Clin Epidemiol (2002) 1.07
Morphologic differences between the hips of Chinese women and white women: could they account for the ethnic difference in the prevalence of hip osteoarthritis? Arthritis Rheum (2011) 1.06
The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis. Ann Rheum Dis (2011) 1.05
Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain. Cost Eff Resour Alloc (2009) 1.05
Compliance with a statin treatment in a usual-care setting: retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemia. Clin Ther (2005) 1.05
Does smoking protect against osteoarthritis? Meta-analysis of observational studies. Ann Rheum Dis (2011) 1.05
The effect of genome-wide association scan quality control on imputation outcome for common variants. Eur J Hum Genet (2011) 1.04
Severe vascular events in migraine patients. Headache (2004) 1.04
Guidelines for management of osteoarthritis published by the American College of Rheumatology and the European League Against Rheumatism: why are they so different? Rheum Dis Clin North Am (2003) 1.03
Role of the Nav1.7 R1150W amino acid change in susceptibility to symptomatic knee osteoarthritis and multiple regional pain. Arthritis Care Res (Hoboken) (2010) 1.02
Association between a variation in LRCH1 and knee osteoarthritis: a genome-wide single-nucleotide polymorphism association study using DNA pooling. Arthritis Rheum (2006) 1.02
Dopamine antagonists and the development of breast cancer. Arch Gen Psychiatry (2002) 1.01
The incidence of abdominal and pelvic surgery among patients with irritable bowel syndrome. Dig Dis Sci (2005) 1.01
Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies. Arthritis Rheumatol (2014) 1.00
Mutations in the amino terminus of ANKH in two US families with calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum (2003) 0.98
Mild acetabular dysplasia and risk of osteoarthritis of the hip: a case-control study. Ann Rheum Dis (2010) 0.96
Gout. BMJ (2013) 0.95
Chondrocalcinosis is common in the absence of knee involvement. Arthritis Res Ther (2012) 0.95
Identification of abacavir hypersensitivity reaction in health care claims data. Pharmacoepidemiol Drug Saf (2007) 0.95
International position paper on febuxostat. Clin Rheumatol (2010) 0.95
How important are genetic factors in osteoarthritis? Contributions from family studies. J Rheumatol (2005) 0.94
A role for PACE4 in osteoarthritis pain: evidence from human genetic association and null mutant phenotype. Ann Rheum Dis (2012) 0.94
Thrombospondin 1 mediates renal dysfunction in a mouse model of high-fat diet-induced obesity. Am J Physiol Renal Physiol (2013) 0.93
The incidence of first provoked and unprovoked seizure in pediatric patients with and without psychiatric diagnoses. Epilepsia (2007) 0.92
What if we prevent obesity? Risk reduction in knee osteoarthritis estimated through a meta-analysis of observational studies. Arthritis Care Res (Hoboken) (2011) 0.92
Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users. Contraception (2010) 0.92
The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database. Curr Drug Saf (2008) 0.92
Incidence of colonic ischemia, hospitalized complications of constipation, and bowel surgery in relation to use of alosetron hydrochloride. Am J Gastroenterol (2003) 0.92